Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Natsuki Kubota-Ishida"'
Publikováno v:
European journal of pharmacology. 906
Atopic dermatitis (AD) is a chronic inflammatory skin disease that is commonly treated with corticosteroids. However, these drugs have long-term adverse effects, representing an unmet need for new treatments. AD is associated with dysregulation of ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::728114352adab7e4c0371dee8a4c42de
https://pubmed.ncbi.nlm.nih.gov/34139195
https://pubmed.ncbi.nlm.nih.gov/34139195
Autor:
Matsuhira Takashi, Takashi Iwanaga, Osamu Nishiyama, Yuji Tabata, Hiroyuki Sano, Natsuki Kubota-Ishida, Chizuko Kaji, Yasutaka Chiba, Yuji Tohda
Publikováno v:
European Journal of Pharmacology. 885:173508
Idiopathic pulmonary fibrosis (IPF) is an intractable disease with poor prognosis, and therapeutic options are limited. While the pathogenic mechanism is unknown, cytokines, such as transforming growth factor (TGF)-β, and immune cells, such as monoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6ed90184fa1ef2909d0283d49711c31
https://doi.org/10.1016/j.ejphar.2020.173508
https://doi.org/10.1016/j.ejphar.2020.173508
Autor:
Kaori Kaneda, Yuji Tabata, Naomi Takei-Masuda, Sho Takahata, Yu Nagira, Xiaoying Hui, Masahiro Nomoto, Natsuki Kubota-Ishida, Howard I. Maibach, Tsubasa Chikada, Kazunori Maebashi
Publikováno v:
Antimicrobial agents and chemotherapy, vol 62, iss 1
ME1111 is a novel antifungal agent currently under clinical development as a topical onychomycosis treatment. A major challenge in the application of topical onychomycotics is penetration and dissemination of antifungal agent into the infected nail p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9606d621f3ccbe3379f8bba134472b2
https://europepmc.org/articles/PMC5740379/
https://europepmc.org/articles/PMC5740379/
